Difference between revisions of "Carboplatin, Pemetrexed, Pembrolizumab in advanced or metastatic non-small cell lung cancer"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Replaced content with "<includeonly>Source: Carboplatin, Pemetrexed, Pembrolizumab in advanced or metastatic non-small cell lung cancer {| class="wikitable" style="float:right; margin-left:...")
Tag: Replaced
m (Text replacement - "{| class="wikitable" style="float:right; margin-left: 5px;" |- |back to top |}" to "")
 
Line 1: Line 1:
 
<includeonly>Source: [[Carboplatin, Pemetrexed, Pembrolizumab in advanced or metastatic non-small cell lung cancer]]
 
<includeonly>Source: [[Carboplatin, Pemetrexed, Pembrolizumab in advanced or metastatic non-small cell lung cancer]]
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
</includeonly>
−
|-
 
−
|[[#top|back to top]]
 
−
|}</includeonly>
 
 
<noinclude>
 
<noinclude>
 
{{TOC limit|limit=3}}
 
{{TOC limit|limit=3}}

Latest revision as of 11:19, 26 July 2022



Regimen in use at


Regimen

Retrieved from "https://hemonc.org/w/index.php?title=Carboplatin,_Pemetrexed,_Pembrolizumab_in_advanced_or_metastatic_non-small_cell_lung_cancer&oldid=57770"